Physician profile
Randall E Pearson
NPI 1639179682
$646.44
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $29.81 · 2023: $17.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $131.90 | 2019 | |
| Astellas Pharma US INC | $87.43 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $76.04 | 2019 | |
| Ferring Pharmaceuticals INC. | $47.91 | 2019 | |
| Pfizer INC. | $47.57 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $42.55 | 2019 | |
| Zyla Life Sciences, INC. | $31.51 | 2019 | |
| Abbvie INC. | $31.16 | 2019 | |
| Janssen Biotech, INC. | $23.04 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.14 | 2019 | |
| Boston Scientific Corporation | $21.57 | 2019 | |
| 180 Medical, INC. | $20.34 | 2019 | |
| Aytu Biopharma, INC. | $19.13 | 2019 | |
| Merck Sharp & Dohme LLC | $17.29 | 2023 | Bridion |
| Rochester Medical Corporation | $14.21 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.